The promise of data-driven medicine is that it can accelerate the diagnosis of disease, provide patients with the most effective treatments for their particular conditions, and improve drug development. Sophia Genetics is drawing on extensive information from its global, data-sharing network to make data-driven medicine a reality. We spoke to Emily Paul, product director of platform for Sophia Genetics, about Sophia’s vision for data-driven medicine, the challenges of managing vast amounts of data and turning it into actionable information, and how its changing patient care today.
Fler avsnitt av The Bio Report
Visa alla avsnitt av The Bio ReportThe Bio Report med Levine Media Group finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
